{"title":"265 nm紫外线C光治疗多重耐药铜绿假单胞菌角膜炎的体外和体内实验研究。","authors":"Lakshminarayanan Gowtham , Esther Sheba , Savitri Sharma , Dilip Kumar Mishra , Bhupesh Bagga","doi":"10.1016/j.clae.2025.102417","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>This study evaluated the <em>in vitro</em> and <em>in vivo</em> efficacy of 265 nanometer (nm) ultraviolet C (UVC) light using 1.93 mW/cm<sup>2</sup> against multi-drug-resistant (MDR) <em>Pseudomonas aeruginosa</em> (<em>P. aeruginosa</em>) keratitis.</div></div><div><h3>Methods</h3><div>The effect of UVC light was studied on two clinical isolates of <em>P. aeruginosa</em>. Isolate 1 was ciprofloxacin-susceptible, and isolate 2 was MDR (but ceftazidime-susceptible). For the <em>in vitro</em> evaluation, <em>P. aeruginosa</em> isolates (100 μl, 1*10<sup>8</sup> CFU/ml) were spread on Muller-Hinton solid agar surface and exposed to UVC light for 1, 5, 10, 15, and 30 seconds (s). For the <em>in vivo</em> study, the right eyes of C57BL mice were infected with the <em>P. aeruginosa</em> isolates (5 μL, 1*10<sup>8</sup> CFU/ml) in two sets with isolates 1 and 2, respectively. The first set (n = 24) was randomized into four groups: a) untreated, b) UVC light 15 s exposure twice daily for two days, c) topical ciprofloxacin 0.3 %w/v twice daily for two days, d) topical ciprofloxacin 0.3 %w/v two-hourly for two days. The second set with MDR <em>P. aeruginosa</em> (n = 24) was treated similarly except for group d (which received topical ceftazidime 5 %w/v two hourly for two days). The left eyes were used to evaluate the safety of applied treatments without inducing infection. At 48 hours (hrs), eyes were enucleated and subjected to microbiological and histopathology analysis.</div></div><div><h3>Results</h3><div><em>In vitro</em>, the UVC light exposure resulted in a clear inhibition area for exposures of 15 and 30 s. In the <em>in vivo</em> murine model, UVC light prevented overall clinical severity (p < 0.05) at 24 and 48 hrs by both isolates. Microbiological assessment at 48 hrs showed no growth of organisms in UVC light-treated corneas of either of the sets, similar to an observed treatment with ciprofloxacin (set 1) and ceftazidime (set 2).</div></div><div><h3>Conclusion</h3><div>265 nm UVC light showed an exposure-dependent <em>in vitro</em> bactericidal effect on <em>P. aeruginosa</em>. The <em>in vivo</em> studies showed that UVC light eliminated both strains of <em>P. aeruginosa</em> with an equivalent efficacy.</div></div>","PeriodicalId":49087,"journal":{"name":"Contact Lens & Anterior Eye","volume":"48 4","pages":"Article 102417"},"PeriodicalIF":4.1000,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Efficacy of 265 nm ultraviolet C light in the treatment of multi-drug resistant Pseudomonas aeruginosa keratitis in vitro and in an in vivo murine model\",\"authors\":\"Lakshminarayanan Gowtham , Esther Sheba , Savitri Sharma , Dilip Kumar Mishra , Bhupesh Bagga\",\"doi\":\"10.1016/j.clae.2025.102417\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>This study evaluated the <em>in vitro</em> and <em>in vivo</em> efficacy of 265 nanometer (nm) ultraviolet C (UVC) light using 1.93 mW/cm<sup>2</sup> against multi-drug-resistant (MDR) <em>Pseudomonas aeruginosa</em> (<em>P. aeruginosa</em>) keratitis.</div></div><div><h3>Methods</h3><div>The effect of UVC light was studied on two clinical isolates of <em>P. aeruginosa</em>. Isolate 1 was ciprofloxacin-susceptible, and isolate 2 was MDR (but ceftazidime-susceptible). For the <em>in vitro</em> evaluation, <em>P. aeruginosa</em> isolates (100 μl, 1*10<sup>8</sup> CFU/ml) were spread on Muller-Hinton solid agar surface and exposed to UVC light for 1, 5, 10, 15, and 30 seconds (s). For the <em>in vivo</em> study, the right eyes of C57BL mice were infected with the <em>P. aeruginosa</em> isolates (5 μL, 1*10<sup>8</sup> CFU/ml) in two sets with isolates 1 and 2, respectively. The first set (n = 24) was randomized into four groups: a) untreated, b) UVC light 15 s exposure twice daily for two days, c) topical ciprofloxacin 0.3 %w/v twice daily for two days, d) topical ciprofloxacin 0.3 %w/v two-hourly for two days. The second set with MDR <em>P. aeruginosa</em> (n = 24) was treated similarly except for group d (which received topical ceftazidime 5 %w/v two hourly for two days). The left eyes were used to evaluate the safety of applied treatments without inducing infection. At 48 hours (hrs), eyes were enucleated and subjected to microbiological and histopathology analysis.</div></div><div><h3>Results</h3><div><em>In vitro</em>, the UVC light exposure resulted in a clear inhibition area for exposures of 15 and 30 s. In the <em>in vivo</em> murine model, UVC light prevented overall clinical severity (p < 0.05) at 24 and 48 hrs by both isolates. Microbiological assessment at 48 hrs showed no growth of organisms in UVC light-treated corneas of either of the sets, similar to an observed treatment with ciprofloxacin (set 1) and ceftazidime (set 2).</div></div><div><h3>Conclusion</h3><div>265 nm UVC light showed an exposure-dependent <em>in vitro</em> bactericidal effect on <em>P. aeruginosa</em>. The <em>in vivo</em> studies showed that UVC light eliminated both strains of <em>P. aeruginosa</em> with an equivalent efficacy.</div></div>\",\"PeriodicalId\":49087,\"journal\":{\"name\":\"Contact Lens & Anterior Eye\",\"volume\":\"48 4\",\"pages\":\"Article 102417\"},\"PeriodicalIF\":4.1000,\"publicationDate\":\"2025-04-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Contact Lens & Anterior Eye\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1367048425000517\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contact Lens & Anterior Eye","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1367048425000517","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
Efficacy of 265 nm ultraviolet C light in the treatment of multi-drug resistant Pseudomonas aeruginosa keratitis in vitro and in an in vivo murine model
Background
This study evaluated the in vitro and in vivo efficacy of 265 nanometer (nm) ultraviolet C (UVC) light using 1.93 mW/cm2 against multi-drug-resistant (MDR) Pseudomonas aeruginosa (P. aeruginosa) keratitis.
Methods
The effect of UVC light was studied on two clinical isolates of P. aeruginosa. Isolate 1 was ciprofloxacin-susceptible, and isolate 2 was MDR (but ceftazidime-susceptible). For the in vitro evaluation, P. aeruginosa isolates (100 μl, 1*108 CFU/ml) were spread on Muller-Hinton solid agar surface and exposed to UVC light for 1, 5, 10, 15, and 30 seconds (s). For the in vivo study, the right eyes of C57BL mice were infected with the P. aeruginosa isolates (5 μL, 1*108 CFU/ml) in two sets with isolates 1 and 2, respectively. The first set (n = 24) was randomized into four groups: a) untreated, b) UVC light 15 s exposure twice daily for two days, c) topical ciprofloxacin 0.3 %w/v twice daily for two days, d) topical ciprofloxacin 0.3 %w/v two-hourly for two days. The second set with MDR P. aeruginosa (n = 24) was treated similarly except for group d (which received topical ceftazidime 5 %w/v two hourly for two days). The left eyes were used to evaluate the safety of applied treatments without inducing infection. At 48 hours (hrs), eyes were enucleated and subjected to microbiological and histopathology analysis.
Results
In vitro, the UVC light exposure resulted in a clear inhibition area for exposures of 15 and 30 s. In the in vivo murine model, UVC light prevented overall clinical severity (p < 0.05) at 24 and 48 hrs by both isolates. Microbiological assessment at 48 hrs showed no growth of organisms in UVC light-treated corneas of either of the sets, similar to an observed treatment with ciprofloxacin (set 1) and ceftazidime (set 2).
Conclusion
265 nm UVC light showed an exposure-dependent in vitro bactericidal effect on P. aeruginosa. The in vivo studies showed that UVC light eliminated both strains of P. aeruginosa with an equivalent efficacy.
期刊介绍:
Contact Lens & Anterior Eye is a research-based journal covering all aspects of contact lens theory and practice, including original articles on invention and innovations, as well as the regular features of: Case Reports; Literary Reviews; Editorials; Instrumentation and Techniques and Dates of Professional Meetings.